Endothelial Disfunction Treatment With Glimepiride/Metformin Combination (Glimetal) in Type 2 Diabetes Patients
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The Purpose of this study was to evaluate the effect of the combination glimepiride/metformin
over endothelial dysfunction (ED) in asymptomatic patients with type 2 diabetes mellitus (DM)
using 13N-ammonia-positron emission tomography (PET).